Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Fierce Pharma
Novartis telegraphs 130 job cuts in Switzerland
Novartis plans to discontinue small-volume biologics production at its Kleinbasel site by the end of 2027, in a move that could eliminate 130 jobs.
Angus Liu
Sep 2, 2026 2:15pm
Fierce Pharma
ITM cancer drug spurned by FDA over manufacturing qualms
Aug 10, 2026 11:25am
Fierce Pharma
Novo’s Catalent plant ditched in FDA refiling of SMA drug
Aug 10, 2026 10:06am
Fierce Pharma
Merck prepares expanded access to monthly PrEP pill early
Jul 24, 2026 10:40am
Fierce Pharma
FDA snubs Sobi’s gout drug over manufacturing issues
Jun 29, 2026 11:04am
Fierce Pharma
Medline earns FDA warning letter ire for repeat bacteria issues
Jun 4, 2026 7:36am